ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
69,358.49
1.24%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC
  6. Silence Therapeutics PLC (PK) (SLNCF)

  7. Silence Therapeutics PLC (PK) (SLNCF) 뉴스

SLNCF

Silence Therapeutics (PK) (SLNCF)

Silence Therapeutics PLC (PK)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:SLNCF
일자시간출처헤드라인심볼기업
2024/05/0806:03Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersUSOTC:SLNCFSilence Therapeutics PLC (PK)
2023/12/0121:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/11/0120:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/08/1620:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/08/1506:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/07/0320:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/05/1705:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/05/0120:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/03/2821:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/02/0905:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SLNCFSilence Therapeutics PLC (PK)
2023/01/1306:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/11/1022:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/10/2105:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/09/2921:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/08/2305:14Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/08/2005:31Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/08/1302:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/08/1219:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/08/1206:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/06/1605:33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/05/1621:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/05/1621:33Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/04/2521:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/04/0421:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/03/2321:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/03/1801:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/02/2220:52Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/02/1507:23Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/02/1507:12Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:SLNCFSilence Therapeutics PLC (PK)
2022/02/1106:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SLNCFSilence Therapeutics PLC (PK)
 검색 관련기사 보기:USOTC:SLNCF

최근 히스토리

AMEX
FEHY
Flexshares Esg and Clima...
BOV
MDIA3F
M.DIAS BRANCO ON
BIT
CHEU
ETFS Short CHF Long EUR
NASDAQ
WULF
TeraWulf
NASDAQ
IGACU
IG Acquisition
BIBX
LENDBTC
LSE
47ZU
Jyske Bk. 5.67%
NASDAQ
HIFAWX
High 50 Dividend Strateg...
EU
BPCHC
BPCE Bpcezc24oct29
BITMOT
930290
Kfw Tf 1,25% Ge25 Usd
NASDAQ
PGRWW
Progress Acquisition
NASDAQ
FAKGX
Franklin Conservative Al...
EU
Q649S
Q649S
NASDAQ
SCOAW
ScION Tech Growth I
ASX
PKONB
BIT
F12837
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유